ANDREW ILLOBRE: Open Payments
NPI 1598836462 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,824 in 109 payments from 28 companies in 2025. Trend: 2023 $1,667 · 2024 $1,922 · 2025 $1,824
Food & beverage: $1,824
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $359 |
| Novo Nordisk Inc | 15 | $284 |
| AstraZeneca Pharmaceuticals LP | 9 | $196 |
| GlaxoSmithKline, LLC. | 10 | $137 |
| PFIZER INC. | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Exact Sciences Corporation | 4 | $60 |
| Lilly USA, LLC | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 4 | $55 |
Products named: QULIPTA, Ozempic, UBRELVY, AIRSUPRA, FARXIGA, Wegovy, SHINGRIX, XIFAXAN.
Industry payments across NC — which companies pay providers there.
